← All companies

NSRX

Nasus Pharma Ltd.

NSRX NYSE Pharmaceutical Preparations EDGAR ↗

$3.19

+0.16 +5.28%

Key statistics

from XBRL data in SEC filings

Market cap

$28.8M

Revenue (TTM)

$1.24B

Net income (TTM)

-$5.86M

EPS (TTM)

$-0.72

P/E ratio

—

Dividend yield

—

Free cash flow

-$4.93M

Cash

$1.24M

Total assets

$5.00M

Gross margin

—

52-week range

$1.98 – $9.99

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 28, 2026 6-K Jun 9, 2026 6-K Mar 25, 2026 20-F Mar 25, 2026 6-K Mar 16, 2026 6-K Mar 6, 2026 6-K Mar 4, 2026 6-K Feb 24, 2026 6-K Feb 13, 2026 6-K Feb 12, 2026 6-K Jan 29, 2026 6-K Jan 20, 2026 6-K Dec 29, 2025 6-K Dec 22, 2025 6-K Nov 20, 2025 6-K Nov 18, 2025 6-K Nov 3, 2025 6-K Oct 8, 2025 6-K Sep 30, 2025 6-K Sep 5, 2025 6-K Aug 14, 2025

Other filings

3 Jul 31, 2026 4 Jul 29, 2026 4 Jun 22, 2026 S-8 May 26, 2026 SCHEDULE 13G May 15, 2026 4 Apr 22, 2026 SCHEDULE 13G Apr 7, 2026 4 Apr 1, 2026 EFFECT Mar 31, 2026 3 Mar 27, 2026 3 Mar 27, 2026 3 Mar 27, 2026 3 Mar 27, 2026 3 Mar 27, 2026 3 Mar 27, 2026 3 Mar 27, 2026 3 Mar 27, 2026 POS AM Mar 27, 2026 EFFECT Mar 13, 2026